GRAIL: GRids of phArmacophore Interaction fieLds

Area of Science:

• Computational chemistry
• Structural biology
• Drug discovery

Background:

• Experimentally determined 3D structures of ligand-receptor complexes are often unavailable.
• Understanding receptor-ligand interactions is crucial for de novo ligand design and lead optimization.
• Existing methods may be computationally intensive for analyzing large datasets like molecular dynamics simulations.

Purpose of the Study:

• To present a novel computational method, GRAIL, for identifying energetically favorable interaction sites on receptor binding sites.
• To enable efficient analysis of protein structures and dynamics for guiding rational drug design.
• To assess conformation-dependent characteristics of key interactions over time.

Main Methods:

• Combines grid-based approaches with the pharmacophore concept.
• Utilizes a reduced pharmacophoric abstraction for rapid computation of interaction grid maps.
• Applies the method to analyze large coordinate sets from long-time molecular dynamics (MD) simulations.
• Incorporates protein conformational changes into the analysis.

Main Results:

• GRAIL enables rapid computation of interaction grid maps.
• The method facilitates the analysis of conformation-dependent interactions from MD trajectories.
• Demonstrated performance on the oncology target heat shock protein 90 with various inhibitors.
• Provided insights into optimizing molecular features of inhibitors.

Conclusions:

• GRAIL is an effective tool for identifying key interaction sites in receptor binding pockets.
• The method enhances rational ligand design by considering protein dynamics and conformational flexibility.
• GRAIL offers a valuable approach for drug discovery, particularly when experimental structures are limited.